Irfan Gafoor Kazi
About Irfan Gafoor Kazi
Data last updated:
Irfan Gafoor Kazi is a Director at Tawwab Pharma Private Limited (since 2018) and Director at Imia Healthcare Private Limited (since 2025). The companies operate in Pharma and Wood. The largest current company by reported revenue is Tawwab Pharma Private Limited at ₹8.58 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tawwab Pharma Private Limited U74999MH2018PTC312223 | Director | 25 Jul 2018 | 2018 | ₹8.58 Cr (FY 2024) | Active |
 Imia Healthcare Private Limited U20237MH2025PTC443428 | Director | 21 Mar 2025 | 2025 | Active |
Board colleagues of Irfan Gafoor Kazi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mehjabeen Irfan Kazi | 02444678 | Tawwab Pharma Private Limited , Imia Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Irfan Gafoor Kazi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Irfan Gafoor Kazi
Irfan Gafoor Kazi currently holds 2 directorships: Tawwab Pharma Private Limited (Director, since 25 Jul 2018, revenue ₹8.58 Cr (FY 2024)); Imia Healthcare Private Limited (Director, since 21 Mar 2025).
Irfan Gafoor Kazi was first appointed on 25 Jul 2018 as Director at Tawwab Pharma Private Limited. The most recent appointment on record is 21 Mar 2025 at Imia Healthcare Private Limited.
The current boards of Irfan Gafoor Kazi's companies include Mehjabeen Irfan Kazi (Tawwab Pharma Private Limited).